JW Pharmaceutical
As we head into Q2 2023, the hair growth treatment industry continues to develop and make progress in various ways. Kintor Begins Phase 2 Trial For GT20029 Drug This news appeared one day following the publishing of this article. Kintor Pharmaceutical of China has dosed the first patient in a trial which will comprise 180…
Read More
Korean company JW Pharmaceutical announces that it will participate in the upcoming Wnt 2022 Conference to unveil hair growth related data. JW0061 Pipeline Drug For Hair Loss Since 2017, it’s been known that the Wnt pathway specialists at JW Pharmaceutical had their sights set on hair regeneration. It was announced in the media that the company…
Read More